DCPH - Deciphera Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development82,88739,51420,16312,475
Selling General and Administrative21,21211,4215,6755,135
Non Recurring----
Total Operating Expenses104,09950,93525,83817,610
Operating Income or Loss-104,099-50,935-25,838-17,610
Income from Continuing Operations
Total Other Income/Expenses Net4,245651-102-2,206
Earnings Before Interest and Taxes-104,099-50,935-25,838-17,610
Interest Expense-84-95-106-2,209
Income Before Tax-99,854-50,284-25,940-19,816
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-99,854-50,284-25,940-19,816
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-99,854-50,284-25,940-19,816
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-99,854-50,284-25,940-19,816